Literature DB >> 22082547

Advanced adaptive axial-sequential prospectively electrocardiogram-triggered dual-source coronary computed tomographic angiography in a patient with atrial fibrillation.

Manavjot S Sidhu1, Vikram Venkatesh, Udo Hoffmann, Brian B Ghoshhajra.   

Abstract

Atrial fibrillation is considered a relative contraindication to coronary computed tomographic angiography (CCTA) because image quality and radiation dose-saving measures largely depend on low and stable heart rates. Most published experiences with CCTA during atrial fibrillation have relied on retrospective gating to mitigate artifacts via electrocardiogram editing. However, a large number of patients arrive at the CT suite with irregular heart rates. We present a case in which we used a prospectively electrocardiogram-triggered axial-sequential scan mode with a novel arrhythmia protection algorithm to obtain motion-free, high-quality CCTA images at a low radiation dose.

Entities:  

Mesh:

Year:  2011        PMID: 22082547     DOI: 10.1097/RCT.0b013e3182355960

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  2 in total

1.  Assessment of image quality and radiation dose of prospectively ECG-triggered adaptive dual-source coronary computed tomography angiography (cCTA) with arrhythmia rejection algorithm in systole versus diastole: a retrospective cohort study.

Authors:  Ashley M Lee; Jonathan Beaudoin; Leif-Christopher Engel; Manavjot S Sidhu; Suhny Abbara; Thomas J Brady; Udo Hoffmann; Brian B Ghoshhajra
Journal:  Int J Cardiovasc Imaging       Date:  2013-03-24       Impact factor: 2.357

2.  Salvage of diagnostic quality of image acquired by low-radiation-dose prospectively ECG-triggered coronary CTA during ventricular trigeminy: A case report of a novel image processing method.

Authors:  Harshna V Vadvala; Karl Sayegh; Matthew Moy; Pedro Vinícius Staziaki; Brian B Ghoshhajra
Journal:  HeartRhythm Case Rep       Date:  2015-09-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.